Women’s Health Diagnostics Market by Application (HPV, Fertility Test, Pregnancy Test, Prenatal Testing, Down Syndrome, Osteoporosis, Urinary Tract Infections, Cervical and Ovarian Cancer Test, Breast), End User (Home Care, Hospitals) – 2019 to 2024

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: March 23, 2020
Clear
SKU: GMS-3039 Category:

The global market for women’s health diagnostics is expected to hit USD 39.2 billion by 2025, rising in the forecast period at a CAGR of about 6.53%. Factors such as increased awareness of various health-related disorders among women, increased occurrence of various chronic and lifestyle disorders among women and high prevalence of infectious diseases such as HIV and hepatitis among women worldwide are driving market growth.

Women’s Health Diagnostics Market by Application (HPV, Fertility Test, Pregnancy Test, Prenatal Testing, Down Syndrome, Osteoporosis, Urinary Tract Infections, Cervical and Ovarian Cancer Test, Breast), End User (Home Care, Hospitals) - 2019 to 2024 1

Women’s Health Diagnostics Market by Application (HPV, Fertility Test, Pregnancy Test, Prenatal Testing, Down Syndrome, Osteoporosis, Urinary Tract Infections, Cervical and Ovarian Cancer Test, Breast), End User (Home Care, Hospitals) - 2019 to 2024 2

Women’s Health Diagnostics Market by Application (HPV, Fertility Test, Pregnancy Test, Prenatal Testing, Down Syndrome, Osteoporosis, Urinary Tract Infections, Cervical and Ovarian Cancer Test, Breast), End User (Home Care, Hospitals) - 2019 to 2024 3

Women’s Health Diagnostics Market by Application (HPV, Fertility Test, Pregnancy Test, Prenatal Testing, Down Syndrome, Osteoporosis, Urinary Tract Infections, Cervical and Ovarian Cancer Test, Breast), End User (Home Care, Hospitals) - 2019 to 2024 4

Women’s Health Diagnostics Market by Application (HPV, Fertility Test, Pregnancy Test, Prenatal Testing, Down Syndrome, Osteoporosis, Urinary Tract Infections, Cervical and Ovarian Cancer Test, Breast), End User (Home Care, Hospitals) - 2019 to 2024 5

Women’s Health Diagnostics Market by Application (HPV, Fertility Test, Pregnancy Test, Prenatal Testing, Down Syndrome, Osteoporosis, Urinary Tract Infections, Cervical and Ovarian Cancer Test, Breast), End User (Home Care, Hospitals) - 2019 to 2024 6

Women’s Health Diagnostics Market by Application (HPV, Fertility Test, Pregnancy Test, Prenatal Testing, Down Syndrome, Osteoporosis, Urinary Tract Infections, Cervical and Ovarian Cancer Test, Breast), End User (Home Care, Hospitals) - 2019 to 2024 7

Women’s Health Diagnostics Market by Application (HPV, Fertility Test, Pregnancy Test, Prenatal Testing, Down Syndrome, Osteoporosis, Urinary Tract Infections, Cervical and Ovarian Cancer Test, Breast), End User (Home Care, Hospitals) - 2019 to 2024 8

1 Global Women’s Health Diagnostics Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Women’s Health Diagnostics Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Women’s Health Diagnostics Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Women’s Health Diagnostics Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Women’s Health Diagnostics Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Women’s Health Diagnostics Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Women’s Health Diagnostics Market – By Application
8.1 Breast Cancer Testing
8.2 Infectious Disease Testing
8.3 Cervical Cancer Testing
8.4 Sexually Transmitted Disease Testing
8.5 Osteoporosis Testing
8.6 Ultrasound
8.7 Pregnancy and Fertility Testing
8.8 Ovarian Cancer Testing

9 Global Women’s Health Diagnostics Market – By End-User
9.1 Hospitals and Clinics
9.2 Home Care
9.3 Diagnostic and Imaging Centers

10 Global Women’s Health Diagnostics Market – By Geography (Market Size – &
million/billion)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 U.K
10.3.2 Germany
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Rest of the World
10.5.1 South America
10.5.2 Middle East
10.5.3 Africa

11 Global Women’s Health Diagnostics Market – Entropy
11.1 New product launches
11.2 M&A’s, collaborations, JVs and partnerships

12 Global Women’s Health Diagnostics Market Company Profile (Key Players)
12.1 Market Share, Company Revenue, Products, M&A, Developments
12.2 Siemens AG
12.3 GE Healthcare
12.4 Becton, Dickinson and Company
12.5 Quest Diagnostics Inc.
12.6 Hologic, Inc.
12.7 Abbott Laboratories
12.8 Biomérieux SA
12.9 F. Hoffmann-La Roche AG
12.10 Perkinelmer Inc.
12.11 Alere Inc.
12.12 Company 11 & more

13 Global Women’s Health Diagnostics Market – Appendix
13.1 Sources
13.2 Abbreviations